Référentiel des médicaments
Metreleptin
Metreleptin is a medicine in the class endocrine.
- Classe médicamenteuse: Endocrine
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Endocrine
- Formes courantes
- injection
- Dosages courants
- 11.3 mg/2.2 ml
- Interactions connues
- 23 (Majeure: 4 · Modérée: 19)
- Noms commerciaux
- 2
- Pays et marchés
- 2
Mécanisme d'action
Leptin analog that binds to and activates the human leptin receptor (ObR), a Class I cytokine receptor that signals through the JAK/STAT pathway, replacing deficient leptin in generalized lipodystrophy.
Posologie adulte habituelle (résumé de la notice)
Generalized lipodystrophy, males greater than 40 kg: start 2.5 mg subcutaneously once daily; adjust by 1.25 mg to 2.5 mg; maximum 10 mg/day
Grossesse et allaitement
- Grossesse
- Unknown Pregnancy reports are too few to show a risk. In mice, prolonged labour, maternal deaths at birth and lower pup survival occurred from about the maximum human dose. If used in pregnancy, mix with preservative-free water (the bacteriostatic diluent has benzyl alcohol).
- Allaitement
- Unknown No data on metreleptin in milk; natural leptin is a normal milk component. It is a protein, so little is expected to be absorbed by the infant. No LactMed record. US label: weigh breastfeeding against the mother's need.
Effets indésirables signalés
- Headache
- Hypoglycemia
- Decreased weight
- Abdominal pain
- Arthralgia
- Dizziness
Mises en garde encadrées
- Neutralizing anti-metreleptin antibodies have been identified; they could inhibit endogenous leptin action and/or cause loss of efficacy. Severe infection and/or worsening metabolic control have been reported. Test for neutralizing antibodies in patients with severe infections or suspected loss of efficacy.
Contre-indications
- General obesity not associated with congenital leptin deficiency.
- Prior severe hypersensitivity reactions to metreleptin or any product component.
Précautions particulières
- Neutralizing antibodies may inhibit endogenous leptin and cause loss of efficacy; test if severe infections or loss of efficacy occur.
- T-cell lymphoma: consider benefits and risks in patients with acquired generalized lipodystrophy or significant hematologic abnormalities.
- Hypoglycemia with concomitant insulin or insulin secretagogues; monitor blood glucose.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Principales interactions (23)
- Insulin aspart + Metreleptin Major
- Insulin glargine + Metreleptin Major
- Insulin glargine-lixisenatide + Metreleptin Major
- Insulin lispro + Metreleptin Major
- Chlorpropamide + Metreleptin Moderate
- Cyclosporin + Metreleptin Moderate
- Gliclazide + Metreleptin Moderate
- Glimepiride + Metreleptin Moderate
- Glimepiride-pioglitazone + Metreleptin Moderate
- Glipizide + Metreleptin Moderate
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Metreleptin : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Questions fréquentes
What is Metreleptin used for?
Metreleptin is a medicine in the class endocrine.
What side effects have been reported with Metreleptin?
Headache, Hypoglycemia, Decreased weight, Abdominal pain, Arthralgia, Dizziness. Serious warning: Neutralizing anti-metreleptin antibodies have been identified; they could inhibit endogenous leptin action and/or cause loss of efficacy.
Can Metreleptin be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Pregnancy reports are too few to show a risk. In mice, prolonged labour, maternal deaths at birth and lower pup survival occurred from about the maximum human dose. If used in pregnancy, mix with preservative-free water (the bacteriostatic diluent has benzyl alcohol). Breastfeeding: Unknown. No data on metreleptin in milk; natural leptin is a normal milk component. It is a protein, so little is expected to be absorbed by the infant. No LactMed record. US label: weigh breastfeeding against the mother's need.
What does Metreleptin interact with?
MediHelp lists 23 known interactions for Metreleptin. Major: 4 · Moderate: 19. The most serious include Insulin aspart, Insulin glargine, Insulin glargine-lixisenatide.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
